Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats

Amino Acids

Volumn 23, Issue 1-3, 2002, Pages 213-216

  Wieronska, J M ^a   Szewczyk, B ^a   Branski, P ^a   Palucha, A ^a   Pilc, A ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Animal models of depression; Antidepressant effects; Excitatory amino acids; Metabotropic glutamate receptors; mGlu5 receptors; MPEP; Olfactory bulbectomy

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; DESIPRAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; LEARNING DISORDER; LONG TERM CARE; MALE; NONHUMAN; OLFACTORY BULBECTOMY; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TASK PERFORMANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DESIPRAMINE; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; LEARNING; MALE; OLFACTORY BULB; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

ANIMALIA;

EID: 0036386865     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-001-0131-5     Document Type: Conference Paper

References (30)

1. Ali-Kodja F, Bougard M, Perrault G, Zivkovic B (1980) Effect of serotonin uptake inhibitors on the immobility of mice in the tail suspension test. Br J Pharmacol 87: 130
2. Bajkowska M, Branski P, Smialowska M, Pilc A (1999) Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus. Pol J Pharmacol 51: 539-541
3. Cairncross KD, Cox B, Forster C, Wren AF (1979) Olfactory projection systems, drugs and behaviour: a review. Psychoneuroendocrinology 4: 253-272
4. Chojnacka-Wojcik E, Tatarczynska E, Pilc A (1997) The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. Eur J Pharmacol 319: 153-156
5. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205-237
6. Fitzjohn SM, Irving AJ, Palmer MJ, Harvey J, Lodge D, Collingridge GL (1996) Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neurosci Lett 203: 211-213
7. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-methyl-6-(Phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38: 1493-1503
8. Glaum SR, Miller RJ (1993) Activation of metabotropic glutamate receptors produces reciprocal regulation of ionotropic glutamate and GABA responses in the nucleus of the tractus solitarius of the rat. J Neurosci 13: 1636-1641
9. Glaum SR, Miller RJ (1994) Acute regulation of synaptic transmission by metabotropic glutamate receptors. In: Conn PJ, Patel J (eds) Humana Press, Totowa, NJ, pp 147-172
10. Jancsar SM, Leonard BE (1984) Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog Neuropsychopharmacol Biol Psychiatry 8: 263-269
11. Jesberger JA, Richardson JS (1985) Animal models of depression: parallels and correlates to severe depression in humans. Biol Psychiatry 20: 764-784
12. Joly D, Sanger DJ (1986) The effects offluoxetine and zimeldine on the behavior of olfactory bulbectomized rats. Pharmacol Biochem Behav 24: 199-204
13. Layer RT, Popik P, Olds T, Skolnick P (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52: 621-627
14. Leonard BE, Tuite M (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22: 251-286
15. Lloyd KG, Morselli PL, Depoortere H, Fournier V, Zivkovic B, Scatton B, Broekkamp C, Worms P, Bartholini G (1983) The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav 18: 957-966
16. Mc Geer PL, Eccles JC, Mc Geer EG (1987) Molecular neurobiology of the mammalian brain. Plenum Press, New York
17. Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29: 365-402
18. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504
19. Nicoletti F, Bruno V, Copani A, Casabona G, Knopfel T (1996) Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? Trends Neurosci 19: 267-271
20. Pilc A, Branski P, Palucha A, Tokarski K, Bijak M (1998) Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region. Eur J Pharmacol 349: 83-87
21. Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34: 1-26
22. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391
23. Skolnick P (1999) Antidepressants for the new millennium. Eur J Pharmacol 375: 31-40
24. Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R (1996) Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression. Pharmacopsychiatry 29: 23-26
25. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370
26. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001) Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132: 1423-1430
27. Ugolini A, Corsi M, Bordi F (1999) Potentiation of NMDA and AMPA responses by the specific mGluR(5) agonist CHPG in spinal cord motoneurons. Neuropharmacology 38: 1569-1576
28. van Riezen H, Schnieden H, Wren AF (1977) Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br J Pharmacol 60: 521-528
29. Varney MA, Cosford NDP, Jachec C, Rao SP, Sacaan A, Lin FF, Bleicher L, Santori EM, Flor PJ, Allgeier H, Gasparini F, Kuhn R, Hess SD, Velicelebi G, Johnson EC (1999) SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J Pharmacol Exp Ther 290: 170-181
30. Zahorodna A, Bijak M (1999) An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I metabotropic glutamate receptor activation. Eur J Pharmacol 386: 173-179